Physicians Want More Education, Treatment Options for Future Tumor Genomic Profiling Trials

NEW YORK – Most physician participants expressed satisfaction with the care provided to patients enrolled in the National Cancer Institute's Molecular Analysis for Therapy Choice (MATCH) study, despite barriers like increased workload and long wait times for results, according to recently published survey results.